Notably, recent industry conferences such as the Obesity Week Conference, the American Diabetes Association (ADA) Scientific Sessions, and the European Association for the Study of Diabetes (EASD) Annual Meeting have served as pivotal platforms for presenting real-world evidence and clinical trial updates on Zepbound and other incretin-based therapies
Both oral and subcutaneous semaglutide have been linked with gastrointestinal disturbances, such as nausea, vomiting and diarrhoea.35 However, the data on the association between semaglutide use and the risk of acute pancreatitis remains controversial
Cancer Biol Med
In a clinical study involving people with type 2 diabetes, daily psyllium supplementation improved blood sugar control, insulin sensitivity, and weight over eight weeks
Most people prefer taking them in the morning on an empty stomach, though they may also be taken before meals as directed
For our members, this means a new, convenient oral pathway for sustainable weight management alongside our injectable options
